Search by Drug Name or NDC

NDC 71858-0305-02 LICART 0.013 g/1 Details

LICART 0.013 g/1

LICART is a TOPICAL SYSTEM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by IBSA Pharma Inc.. The primary component is DICLOFENAC EPOLAMINE.

MedlinePlus Drug Summary

Transdermal diclofenac is used to treat short-term pain due to minor strains, sprains, and bruises in adults and children 6 years of age and older. Diclofenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the body's production of a substance that causes pain.

Related Packages: 71858-0305-02
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Diclofenac Transdermal Patch

Product Information

NDC	71858-0305
Product ID	71858-0305_0b72418c-f33d-6338-e063-6394a90a8e0a
Associated GPIs	90210030208520
GCN Sequence Number	079402
GCN Sequence Number Description	diclofenac epolamine PATCH TD24 1.3 % TRANSDERM
HIC3	Q5E
HIC3 Description	TOPICAL ANTI-INFLAMMATORY, NSAIDS
GCN	45883
HICL Sequence Number	020420
HICL Sequence Number Description	DICLOFENAC EPOLAMINE
Brand/Generic	Brand
Proprietary Name	LICART
Proprietary Name Suffix	n/a
Non-Proprietary Name	diclofenac epolamine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SYSTEM
Route	TOPICAL
Active Ingredient Strength	0.013
Active Ingredient Units	g/1
Substance Name	DICLOFENAC EPOLAMINE
Labeler Name	IBSA Pharma Inc.
Pharmaceutical Class	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA206976
Listing Certified Through	2024-12-31

Package

NDC 71858-0305-02 (71858030502)

Pricing Information	N/A
NDC Package Code	71858-0305-2
Billing NDC	71858030502
Package	1 POUCH in 1 CARTON (71858-0305-2) / 2 SYSTEM in 1 POUCH (71858-0305-1)
Marketing Start Date	2020-09-01
NDC Exclude Flag	N